NEW YORK--(BUSINESS WIRE)--Clinical AI-powered healthcare company K Health announced today a new collaboration with Mayo Clinic’s digital healthcare initiative, Mayo Clinic Platform, which harnesses ...

Hypertension is one of the most common chronic conditions in the U.S., affecting nearly half of the country’s adults, according to the Centers for Disease Control and Prevention. Unfortunately, ...

US-based AI company Anumana has revealed results from a study of an algorithm based on electrocardiogram (ECG) designed to recognise signs of pulmonary hypertension (PH) to expedite diagnosis.

CAMBRIDGE, Mass., March 28, 2026--(BUSINESS WIRE)--Anumana, a leader in cardiovascular AI, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its pulmonary hypertension (PH) ...

Please provide your email address to receive an email when new articles are posted on . At diagnosis, the area under the receiver operating characteristic curve in two test sets was 0.92 and 0.88.

The algorithm, developed by data scientists and physicians from Anumana, Janssen and the Mayo Clinic, automatically analyzes ECG readings to predict the likelihood that a patient will be diagnosed ...

The Apple Watch’s new HTNF algorithm now has FDA clearance to issue notifications when it detects patterns suggestive of hypertension Over a 30-day monitoring period, it uses optical sensor data and ...

Anumana has received 510(k) clearance from the US Food and Drug Administration (FDA) for its ECG-AI pulmonary hypertension (PH) detection algorithm, a software-as-a-medical-device (SaMD). The ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, Inc., an AI-driven health technology company from nference, Inc., today announced that the U.S. Food & Drug Administration (FDA) has granted Breakthrough ...